Institutional Ownership
Enliven Therapeutics Inc
CUSIP 29337E102COMELVNQ1 2026
Institutional Holders
169
13F filers
Shares Held
62.36M
Aggregate institutional
Institutional Value
$2.42B
Q1 2026
Net New Holders
+39
57 new · 18 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions57
Increased63
Decreased31
Sold out18
Institutional Holders
169 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 7.96M | $312.01M | 0 | Held |
| 2 | Fmr LLC | 6.83M | $267.71M | −278.4K | Reduced |
| 3 | Polar Capital Holdings PLC | 5.07M | $198.58M | +1.55M | Added |
| 4 | Blackrock, Inc. | 3.68M | $144.44M | +71.4K | Added |
| 5 | Commodore Capital LP | 3.27M | $128.38M | −1.42M | Reduced |
| 6 | Vestal Point Capital, LP | 3.25M | $127.40M | −580.0K | Reduced |
| 7 | Bellevue Group AG | 2.32M | $90.98M | +2.32M | New |
| 8 | Vanguard Capital Management LLC | 2.17M | $84.99M | +2.17M | First Filing |
| 9 | Fairmount Funds Management LLC | 1.86M | $72.74M | −1.86M | Reduced |
| 10 | Citadel Advisors LLC | 1.74M | $68.36M | +319.6K | Added |
159 more institutional holders on Premium
See every fund holding Enliven Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders